| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/29/2000 | CA2356764A1 Type iii secretion system antigens from bordetella pertussis |
| 06/29/2000 | CA2356738A1 Monoclonal antibody against apolipoprotein a-1 |
| 06/29/2000 | CA2356426A1 Method of using a cyclooxygenase-2 inhibitor and a matrix metalloproteinase inhibitor as a combination therapy in the treatment of neoplasia |
| 06/29/2000 | CA2356244A1 Somatic cells with ablated prp gene and methods of use |
| 06/29/2000 | CA2356215A1 Human monoclonal antibodies to ctla-4 |
| 06/29/2000 | CA2355896A1 Antibodies to truncated vegf-d and uses thereof |
| 06/29/2000 | CA2355876A1 Chlamydia trachomatis antigens |
| 06/29/2000 | CA2355364A1 Streptococcus pneumoniae proteins and immunogenic fragments for vaccines |
| 06/29/2000 | CA2355074A1 Lymphocytic membrane proteins |
| 06/29/2000 | CA2354843A1 Outer surface proteins, their genes, and their use |
| 06/29/2000 | CA2354369A1 Complementary dna's encoding proteins with signal peptides |
| 06/29/2000 | CA2354135A1 Group b streptococcus proteins, and their use |
| 06/29/2000 | CA2353960A1 Improvement of tolerance to a xenograft |
| 06/29/2000 | CA2353799A1 Methods and compositions for inhibiting neoplastic cell growth |
| 06/29/2000 | CA2353775A1 Compositions and methods for the treatment of tumor |
| 06/29/2000 | CA2352471A1 Compositions and methods for generating monoclonal antibodies representative of a specific cell type |
| 06/28/2000 | EP1013766A2 Peptides for the detection of HIV-1-Group O |
| 06/28/2000 | EP1013764A1 Immunomodulators |
| 06/28/2000 | EP1013762A2 Delta-like gene expressed in neuroendocrine tumors |
| 06/28/2000 | EP1013761A2 Humanized chimeric antibody directed against ganglioside GD3 |
| 06/28/2000 | EP1013760A2 Stable bactericidal/permeabilityincreasing protein products and pharmaceutical compositions containing the same |
| 06/28/2000 | EP1013757A2 Attenuated forms of bovine viral diarrhea virus |
| 06/28/2000 | EP1013669A2 Method for immobilization of compounds |
| 06/28/2000 | EP1013668A1 Monoclonal antibody against human monocytes |
| 06/28/2000 | EP1013666A2 Methods for obtaining a p53/p90 complex |
| 06/28/2000 | EP1013285A2 Urokinase-type plasminogen activator receptor |
| 06/28/2000 | EP1012577A2 Predisposition to breast cancer by mutations at the ataxia-telangiectasia genetic locus |
| 06/28/2000 | EP1012347A1 Determination and control of bimolecular interactions |
| 06/28/2000 | EP1012343A1 Reagents and methods useful for detecting diseases of the prostate |
| 06/28/2000 | EP1012333A1 ISOLATION OF A NOVEL SENESCENCE-FACTOR GENE, p23 |
| 06/28/2000 | EP1012310A1 Fusion proteins comprising coiled-coil structures |
| 06/28/2000 | EP1012309A2 Chimeric polypeptides containing chemokine domains |
| 06/28/2000 | EP1012308A1 Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors |
| 06/28/2000 | EP1012306A2 Caspase-14, an apoptotic protease, nucleic acids encoding and methods of use |
| 06/28/2000 | EP1012302A1 Human nucleotide pyrophosphohydrolase |
| 06/28/2000 | EP1012299A2 Novel lipid kinase |
| 06/28/2000 | EP1012296A2 Mammalian thioredoxin |
| 06/28/2000 | EP1012292A1 Ntn-2 member of tnf ligand family |
| 06/28/2000 | EP1012288A1 Novel human cystatin-like protein |
| 06/28/2000 | EP1012285A1 Beta-defensins |
| 06/28/2000 | EP1012283A1 Mage-3 peptides presented by hla class ii molecules |
| 06/28/2000 | EP1012282A1 Cysteine rich receptors-train |
| 06/28/2000 | EP1012281A2 Human leukocyte calcium activated potassium channel polypeptide |
| 06/28/2000 | EP1012280A1 Trimerising module |
| 06/28/2000 | EP1012279A1 Mitofusin genes and their uses |
| 06/28/2000 | EP1012278A1 Murine and human cerberus-like proteins and compositions comprising them |
| 06/28/2000 | EP1012275A1 Chimeric antibody fusion proteins for the recruitment and stimulation of an antitumor immune response |
| 06/28/2000 | EP1012274A1 Death domain containing receptor 4 (dr4: death receptor 4), member of the tnf-receptor superfamily and binding to trail (ap02-l) |
| 06/28/2000 | EP1012272A1 Human apoptosis-associated protein; encoding dna is similar to p53 response mouse gene ei124 |
| 06/28/2000 | EP1012270A2 Kay - a novel immune system protein |
| 06/28/2000 | EP1012266A1 Galectin 8, 9, 10 and 10sv |
| 06/28/2000 | EP1012262A1 Human frezzled-like protein |
| 06/28/2000 | EP1012260A1 Interleukin-20 |
| 06/28/2000 | EP1012259A2 Tumor targeted vector |
| 06/28/2000 | EP1012249A1 Plus end-directed microtubule motor required for chromosome congression |
| 06/28/2000 | EP1012248A1 Novel thermophilic polymerase iii holoenzyme |
| 06/28/2000 | EP1012243A1 Monoclonal antibody 3-6-a specific to surface of dendritic cells among the peripheral blood leukocytes |
| 06/28/2000 | EP1012242A1 Human sigma receptor |
| 06/28/2000 | EP1012181A1 Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease |
| 06/28/2000 | EP1012179A2 Cysteine rich receptors: trail |
| 06/28/2000 | EP1012171A1 Modulating the activity of hormones or their receptors - peptides, antibodies, vaccines and uses thereof |
| 06/28/2000 | EP1012162A4 Soluble proteins |
| 06/28/2000 | EP1012162A1 Soluble proteins |
| 06/28/2000 | EP1012160A1 Tango-72 and tango-77 nucleic acid molecules and polypeptides |
| 06/28/2000 | EP1012159A1 Detection and treatment of breast, gynecological and prostate cancer |
| 06/28/2000 | EP1011725A1 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF |
| 06/28/2000 | EP1011724A1 Regulation of osteoclast formation by inhibition of osteoblastic stem cell factor |
| 06/28/2000 | EP1011723A1 88kda tumorigenic growth factor and antagonists |
| 06/28/2000 | EP1011708A1 Anti-peptide antibody against human cytochrome p450 3a4 |
| 06/28/2000 | EP1011703A1 Nucleosome-based anti-tumor compositions |
| 06/28/2000 | EP1011328A1 Stimulation, modulation and/or inhibition of endothelial proteolytic activity and/or angiogenic activity |
| 06/28/2000 | EP0739356B1 Polyclonal antibody to pna/nucleic acid complexes |
| 06/28/2000 | EP0639224B1 Lectin domain variants of selectin |
| 06/28/2000 | EP0557418B1 A beta-type transforming growth factor |
| 06/28/2000 | CN1258319A Vector |
| 06/28/2000 | CN1258315A Mammalian cytokine-like factor-7 |
| 06/28/2000 | CN1257874A Process for preparing antiglobulin of human lymphocyte |
| 06/28/2000 | CN1257873A Adenosine diphosphate ribosylation factor proteinoid |
| 06/28/2000 | CN1257872A Leptospiral vaccine antigen for preventing leptospirosis |
| 06/28/2000 | CN1053964C Immunochemical detection of in vivo advanced glycosylation endproducts |
| 06/28/2000 | CN1053924C Process for preparing CR1 and thrombolytic agent contg. composition |
| 06/27/2000 | USRE36755 DNA encoding tumor necrosis factor-α and -β receptors |
| 06/27/2000 | US6080910 Transgenic mouse comprising a genome with a homozygous disruption of the immunoglobulin gamma 3 gene; for screening compounds for immunizing activity |
| 06/27/2000 | US6080845 Monoclonal antibody against utricular epithelium |
| 06/27/2000 | US6080842 Amino acid sequence; for anticarcinogenic/antitumor agents and treatment of nervous system disorders such as alzheimer's/parkinson's/huntington's diseases; antiepileptic agents; cognition activators; antidepressants |
| 06/27/2000 | US6080841 Human induced tumor protein |
| 06/27/2000 | US6080729 Polypeptides and polynucleotides used to screen for antibacterial compounds |
| 06/27/2000 | US6080718 Useful in the identification and isolation of components involved in transmembrane receptor-mediated signaling |
| 06/27/2000 | US6080717 Treatment of individual having a need to inhibit a polypeptide, comprising administering a bactericidal antagonist of the polypeptide |
| 06/27/2000 | US6080589 Neisseria meningitidis capsular polysacchride conjugates |
| 06/27/2000 | US6080588 Administering derivative to subject to inhibit or prevent disease associated with binding of antibodies to dna; treatment of systemic lupus erythematosus and inflammatory glomerulonephritis |
| 06/27/2000 | US6080582 Cell tests for Alzheimer's disease |
| 06/27/2000 | US6080577 Survival motor neuron (SMN) gene: a gene for spinal muscular atrophy |
| 06/27/2000 | US6080570 Method of producing a vaccine for Swine Infertility and Respiratory Syndrome |
| 06/27/2000 | US6080560 Method for producing antibodies in plant cells |
| 06/27/2000 | US6080558 Polynucleotide encoding human growth regulator protein |
| 06/27/2000 | US6080407 Diagnostic assays for MIF |
| 06/27/2000 | US6080405 Foam proteins and use thereof |
| 06/27/2000 | US6080400 Compositions for the prevention and treatment of verotoxin-induced disease |
| 06/27/2000 | US6080383 Method and composition for the treatment of cancer by the enzymatic conversion of soluble radioactive toxic agents into radioactive toxic precipitates in the cancer |